These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
578 related items for PubMed ID: 29671193
1. Diagnostic performance of 18F-FDG PET/CT and whole-body MRI before and early after treatment of multiple myeloma: a prospective comparative study. Basha MAA, Hamed MAG, Refaat R, AlAzzazy MZ, Bessar MA, Mohamed EM, Ahmed AF, Tantawy HF, Altaher KM, Obaya AA, Afifi AHM. Jpn J Radiol; 2018 Jun; 36(6):382-393. PubMed ID: 29671193 [Abstract] [Full Text] [Related]
4. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis. Machado Medeiros T, Altmayer S, Watte G, Zanon M, Basso Dias A, Henz Concatto N, Hoefel Paes J, Mattiello R, de Souza Santos F, Mohammed TL, Verma N, Hochhegger B. Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513 [Abstract] [Full Text] [Related]
9. Optimization of whole-body 2-[18F]FDG-PET/MRI imaging protocol for the initial staging of patients with myeloma. Burns R, Mulé S, Blanc-Durand P, Tofighi M, Belhadj K, Zerbib P, Le Bras F, Baranes L, Haioun C, Itti E, Luciani A. Eur Radiol; 2022 May; 32(5):3085-3096. PubMed ID: 34842956 [Abstract] [Full Text] [Related]
11. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, Tosi P, Tacchetti P, Cangini D, Perrone G, Ceccolini M, Brioli A, Buttignol S, Fanin R, Salizzoni E, Baccarani M, Fanti S, Cavo M. Haematologica; 2007 Jan; 92(1):50-5. PubMed ID: 17229635 [Abstract] [Full Text] [Related]
14. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D, Salizzoni E, Canini R, Cavo M, Fanti S. Eur J Nucl Med Mol Imaging; 2006 May; 33(5):525-31. PubMed ID: 16453155 [Abstract] [Full Text] [Related]
16. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma. Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S. Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143 [Abstract] [Full Text] [Related]
17. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT. Ng SH, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Lin CY, Chang KP, Lin YC. Eur Radiol; 2010 Sep; 20(9):2229-40. PubMed ID: 20393714 [Abstract] [Full Text] [Related]
18. Agreement Between 18F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With Multiple Myeloma. Gómez León N, Aguado Bueno B, Herreros Pérez M, León Ramírez LF, Alegre A, Colletti PM, Rubello D, Carreras JL, Delgado Bolton RC. Clin Nucl Med; 2021 Apr 01; 46(4):310-322. PubMed ID: 33534256 [Abstract] [Full Text] [Related]
19. Whole-body MRI versus an [18F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin's lymphoma: a prospective multicentre study. Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Enríquez G, Sábado C, Miller E, Granata C, de Lange C, Verzegnassi F, de Keizer B, Nievelstein RAJ. Eur Radiol; 2021 Dec 01; 31(12):8925-8936. PubMed ID: 34021390 [Abstract] [Full Text] [Related]
20. Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT. Herrmann K, Queiroz M, Huellner MW, de Galiza Barbosa F, Buck A, Schaefer N, Stolzman P, Veit-Haibach P. BMC Cancer; 2015 Dec 23; 15():1002. PubMed ID: 26699124 [Abstract] [Full Text] [Related] Page: [Next] [New Search]